Nu Skin Enterprises, Inc. (NYSE:NUS) was the target of unusually large options trading on Wednesday. Stock investors purchased 3,193 put options on the company. This represents an increase of 982% compared to the typical daily volume of 295 put options.
NYSE NUS opened at $59.69 on Friday. Nu Skin Enterprises has a fifty-two week low of $56.09 and a fifty-two week high of $88.68. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.15 and a current ratio of 1.82. The stock has a market cap of $3.27 billion, a price-to-earnings ratio of 16.96, a P/E/G ratio of 1.39 and a beta of 0.68.
Nu Skin Enterprises (NYSE:NUS) last posted its earnings results on Wednesday, February 13th. The company reported $1.05 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $1.05. Nu Skin Enterprises had a return on equity of 25.98% and a net margin of 4.55%. The company had revenue of $683.29 million for the quarter, compared to analyst estimates of $676.76 million. During the same period last year, the company earned $1.20 earnings per share. The business’s revenue was up 2.6% compared to the same quarter last year. Analysts anticipate that Nu Skin Enterprises will post 3.91 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 13th. Stockholders of record on Monday, February 25th were paid a $0.37 dividend. The ex-dividend date was Friday, February 22nd. This is a positive change from Nu Skin Enterprises’s previous quarterly dividend of $0.37. This represents a $1.48 dividend on an annualized basis and a dividend yield of 2.48%. Nu Skin Enterprises’s payout ratio is presently 42.05%.
In other news, General Counsel D Matthew Dorny sold 1,250 shares of the firm’s stock in a transaction on Wednesday, January 2nd. The stock was sold at an average price of $60.60, for a total value of $75,750.00. Following the completion of the sale, the general counsel now owns 32,621 shares of the company’s stock, valued at $1,976,832.60. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 3.00% of the company’s stock.
Institutional investors have recently bought and sold shares of the company. YorkBridge Wealth Partners LLC bought a new position in shares of Nu Skin Enterprises in the fourth quarter worth about $31,000. Harvest Fund Management Co. Ltd increased its stake in shares of Nu Skin Enterprises by 162.9% in the third quarter. Harvest Fund Management Co. Ltd now owns 1,291 shares of the company’s stock worth $106,000 after purchasing an additional 800 shares during the period. NumerixS Investment Technologies Inc bought a new position in shares of Nu Skin Enterprises in the fourth quarter worth about $108,000. Ffcm LLC increased its stake in shares of Nu Skin Enterprises by 181.9% in the third quarter. Ffcm LLC now owns 1,911 shares of the company’s stock worth $177,000 after purchasing an additional 1,233 shares during the period. Finally, First Hawaiian Bank bought a new position in shares of Nu Skin Enterprises in the third quarter worth about $165,000. Institutional investors and hedge funds own 74.29% of the company’s stock.
Several analysts have recently commented on the company. Zacks Investment Research cut Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research report on Thursday, December 20th. Pivotal Research reissued a “buy” rating and set a $85.00 price objective on shares of Nu Skin Enterprises in a research report on Wednesday. ValuEngine cut Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research report on Friday, February 8th. Bank of America set a $65.00 price objective on Nu Skin Enterprises and gave the company a “sell” rating in a research report on Friday, March 1st. Finally, Tigress Financial reissued a “buy” rating on shares of Nu Skin Enterprises in a research report on Wednesday, November 21st. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the company’s stock. Nu Skin Enterprises presently has an average rating of “Buy” and an average target price of $80.25.
TRADEMARK VIOLATION NOTICE: This news story was originally reported by Fairfield Current and is owned by of Fairfield Current. If you are reading this news story on another website, it was stolen and reposted in violation of international copyright laws. The correct version of this news story can be read at https://www.fairfieldcurrent.com/news/2019/03/16/nu-skin-enterprises-target-of-unusually-large-options-trading-nus.html.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.
Featured Article: Return on Investment (ROI)
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.